This suggests that the traditional understanding which links intermediate-length ATXN2 expansions to sporadic ALS, and full-length expansions to SCA2, is not an absolute rule, even though it applies to the majority of cases. This evidence concerns the gene ATXN2 and amyotrophic lateral sclerosis.